IMCL

 
Common Stock SEC Reporting - Delinquent
OTC Pink No Information
Contact Info
  • 1800 Wyoming Avenue, NW
  • 3rd Floor
  • Washington, DC 20009

Business Description


Update Company Profile
 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Oct 31, 2014 10-Q
CIK 0001520047
Fiscal Year End 1/31
OTC Marketplace OTC Pink No Information
Profile Data
SIC - Industry Classification 7374 - Data processing and preparation
Business Status Development Stage Company a/o
Incorporated In: NV, USA
Year of Inc. 2011
Employees 1 a/o Feb 29, 2012
Company Officers/Contacts
Dorothy Bray CEO, President
Chad S. Johnson COO, General Counsel
J. Scott Munro CFO, Principal Acct. Officer
Khadija Benhlhassan CSO
Company Directors
Khadija Benhlhassan
Dorothy Bray
Chad S. Johnson
Company Notes
  • Formerly=Pharma Investing News Inc until 1-2014
Service Providers
Accounting/Auditing Firm
Turner, Stone & Company, L.L.P.
12700 Park Central Drive
Suite 1400
Dallas, TX, 75251
United States

Legal Counsel
Not Available
Investor Relations Firm
Not Available
IMCL Security Details
Share Structure
Market Value1 $3,603,894 a/o Dec 07, 2016
Authorized Shares 290,000,000 a/o May 31, 2012
Outstanding Shares 28,831,154 a/o Dec 22, 2014
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float Not Available
Par Value 0.001
Shareholders
Shareholders of Record Not Available
Short Selling Data
Short Interest 0 (-100%)
Apr 30, 2015
Significant Failures to Deliver No

1Market Value calculated only for respective security